Interventional therapy for hypertension: Back on track again?. (2nd January 2017)

• Record Type: Journal Article
• Authors: Erne, Paul; Sudano, Isabella; Resink, Therese J.; Lüscher, Thomas F.
• Is Part Of: Critical reviews in clinical laboratory sciences. Volume 54:Number 1(2017)
• Page Start: 18
• Page End: 25
• Publication Date: 2017-01-02
• Subjects: Treatment-resistant hypertension -- sympathetic nervous system -- antihypertensive therapy; Diagnosis, laboratory -- Periodicals; Medicine, Clinical -- Periodicals; 616.07
• DOI: 10.1080/10408363.2016.1194367
• Languages: English
• ISSNs: 1040-8363

Abstract

Abstract: Treatment-resistant hypertension, or resistant hypertension, is defined as blood pressure that remains above target despite concurrent use of at least three antihypertensive agents from different classes at optimal doses, one of which should be a diuretic. Important considerations in the diagnosis of treatment-resistant hypertension include the exclusion of pseudoresistance and the evaluation of potential secondary causes of hypertension and of concomitant conditions that maintain high blood pressure. The ability to diagnose true treatment-resistant hypertension is important for selection of patients who may be appropriately treated with an invasive therapy. Currently, there are three interventional approaches to treat resistant hypertension, namely: (1) reduction of the activity of the sympathetic nervous system by renal nerve ablation, (2) stimulation of baroreceptors and (3) creation of a peripheral arterial venous anastomosis. This review focuses on the rationale behind these invasive approaches and the clinical results.